-
Mashup Score: 2Optimal Therapy for Patient with T0 After Neoadjuvant Chemotherapy - Sima Porten, Ananya Choudhury, Paolo Gontero, and Kamal Pohar - 2 year(s) ago
In this discussion, debate presenter, Sima Porten, joins Ashish Kamat along with discussants Ananya Choudhury, Paolo Gontero, and Kamal Pohar. The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer Rapid-fire debates session and here in this UroToday conversation, the group expands on their presentations with Ashish Kamat. The group takes part in a…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Optimal Therapy for Patient with T0 After Neoadjuvant Chemotherapy - Sima Porten, Ananya Choudhury, Paolo Gontero, and Kamal Pohar - 2 year(s) ago
In this discussion, debate presenter, Sima Porten, joins Ashish Kamat along with discussants Ananya Choudhury, Paolo Gontero, and Kamal Pohar. The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer Rapid-fire debates session and here in this UroToday conversation, the group expands on their presentations with Ashish Kamat. The group takes part in a…
Source: UroTodayCategories: Latest Headlines, UrologyTweet-
Optimal therapy for patients with T0 after neoadjuvant chemotherapy. @UroDocAsh is joined by @SimaPorten, Ananya Choudhury, @paolo_gontero, and @PoharKamal discuss a #RapidFire debate presented at the #EAU21 annual meeting. #WatchNow > https://t.co/Ydc6LC1jm4 @Uroweb https://t.co/N6fXcT2pGy
-
-
Mashup Score: 4Optimal Therapy for Patient with T0 After Neoadjuvant Chemotherapy - Sima Porten, Ananya Choudhury, Paolo Gontero, and Kamal Pohar - 3 year(s) ago
In this discussion, debate presenter, Sima Porten, joins Ashish Kamat along with discussants Ananya Choudhury, Paolo Gontero, and Kamal Pohar. The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer Rapid-fire debates session and here in this UroToday conversation, the group expands on their presentations with Ashish Kamat. The group takes part in a…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Optimal therapy for patients with T0 after neoadjuvant chemotherapy. @UroDocAsh is joined by @SimaPorten, Ananya Choudhury, @paolo_gontero, and @PoharKamal discuss a #RapidFire debate presented at the #EAU21 annual meeting. #WatchNow > https://t.co/Ydc6LC1jm4 @Uroweb https://t.co/ajCh9dnIcd
-
-
Mashup Score: 1Optimal Therapy for Patient with T0 After Neoadjuvant Chemotherapy - Sima Porten, Ananya Choudhury, Paolo Gontero, and Kamal Pohar - 3 year(s) ago
In this discussion, debate presenter, Sima Porten, joins Ashish Kamat along with discussants Ananya Choudhury, Paolo Gontero, and Kamal Pohar. The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer Rapid-fire debates session and here in this UroToday conversation, the group expands on their presentations with Ashish Kamat. The group takes part in a…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Optimal therapy for patients with T0 after neoadjuvant chemotherapy. @UroDocAsh is joined by @SimaPorten, Ananya Choudhury, @paolo_gontero, and @PoharKamal discuss a #RapidFire debate presented at the #EAU21 annual meeting. #WatchNow > https://t.co/Ydc6LC1jm4 @Uroweb https://t.co/Y8pAXXnY0u
-
Optimal therapy for patients with T0 after neoadjuvant chemotherapy. @UroDocAsh is joined by @SimaPorten, Ananya Choudhury, @paolo_gontero, and @PoharKamal discuss a #RapidFire debate presented at the #EAU21 annual meeting. #WatchNow > https://t.co/Ydc6LC1jm4 @Uroweb https://t.co/6Ozs0Ohlez